Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are conducting a large observational study across seven European countries to assess the risk of pancreatic cancer in adults with type 2 diabetes mellitus T2DM who start treatment with exenatide compared to those who begin other glucose lowering drugs that are not glucagon-like peptide 1 receptor agonists GLP-1 RA. This study uses long-term data collected retrospectively from prescriptions and insurance records from 2006 to 2023. Patients are matched based on various factors to fairly compare the groups. The study includes two groups one with patients who started exenatide and another with those who started non-GLP-1 RA glucose lowering drugs. Exposure to these treatments is identified through prescription records, and the research focuses on new users of these drugs. The comparison group excludes patients who used GLP-1 RAs or DPP-4 inhibitors before or during the study period. Participants data on prescriptions, diagnoses, and medical history are analyzed to identify new cases of pancreatic cancer during follow-up, which averages about 1.5 years. The study measures how often pancreatic cancer occurs and the relative risk between groups. This safety study does not involve active treatment by researchers but observes outcomes from existing healthcare data until the study ends in 2026.
Actively Recruiting
This research aims to evaluate two different types of digital training programs supervised by physiotherapists compared to daily physical activity in adults with low back pain lasting more than three months. The study also seeks to determine if new MRI methods can detect changes in spine tissue over time and whether these changes differ depending on the type of exercise performed. Participants will be randomly assigned to one of three groups supervised digital training focused on core stability, supervised digital training focused on aerobic exercise, or a non-supervised daily physical activity program with regular physiotherapist support. Each group receives guidance and monitoring relevant to their assigned intervention. Throughout the study, participants will undergo clinical examinations, MRI scans, and complete patient-reported outcome measures at the start, 6 months, and 12 months. Researchers will assess changes in pain, clinical function, muscle condition, and psychological factors, alongside MRI-based tissue changes. This comprehensive follow-up helps track the impact of different exercise approaches on low back pain over one year.